Crossmark

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway

Crossref DOI link: https://doi.org/10.1186/s12885-019-5400-3

Published Online: 2019-03-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lu, Lin

Liu, Qiyao

Wang, Peipei

Wu, Yong

Liu, Xia

Weng, Chengyin

Fang, Xisheng

Li, Baoxiu

Cao, Xiaofei

Mao, Haibo

Wang, Lina

Guan, Mingmei

Wang, Wei

Liu, Guolong http://orcid.org/0000-0001-7391-8750
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81502563)

National Natural Science Foundation of China (81672900)

Natural Science Foundation of Guangdong Province (2016A030310109)

Fundamental Research Funds for the Central Universities (x2xy-D2175050)

Science and Technology Program of Guangzhou (201707010262)
License Information

Text and Data Mining valid from 2019-03-08
More Information

Article History

Received: 25 September 2018

Accepted: 21 February 2019

First Online: 8 March 2019

Ethics approval

: The Ethics Committee of Guangzhou First People’s Hospital approved all the animal experiments. This study did not involve in any human subjects or human material. The cell lines used in this study did not require ethics approval for the use.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.